Merck KGaA Buys Bio-Techne for $11.3B; TECH Pops 20%
Merck KGaA acquires Bio-Techne for $11.3B in cash at $73/share, a 24% premium. TECH jumped 20% to $70.70 and the arb spread of 3.2% signals a tight deal.
Merck KGaA acquires Bio-Techne for $11.3B in cash at $73/share, a 24% premium. TECH jumped 20% to $70.70 and the arb spread of 3.2% signals a tight deal.
Fox’s $160-a-share cash-and-stock bid for Roku closed Friday at $138.07 — a 14% spread that says traders are not convinced the deal closes clean.
Merger arb is the spread between a target’s price and the deal price. Here is the math, the risk, and a worked example on the Paramount-WBD deal.
DOJ cleared Paramount Skydance’s $110.9B Warner Bros takeover June 12, 2026. WBD at $26.84 vs $31 offer — a 15.5% arb spread on remaining risk.